Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$62.12 - $84.15 $2.65 Million - $3.59 Million
-42,605 Reduced 62.24%
25,844 $1.85 Million
Q1 2024

May 15, 2024

SELL
$65.98 - $77.09 $13,459 - $15,726
-204 Reduced 0.3%
68,449 $4.82 Million
Q4 2023

Jan 30, 2024

SELL
$52.83 - $78.22 $1.33 Million - $1.97 Million
-25,151 Reduced 26.81%
68,653 $5.3 Million
Q3 2023

Oct 23, 2023

SELL
$67.52 - $89.42 $483,780 - $640,694
-7,165 Reduced 7.1%
93,804 $6.39 Million
Q2 2023

Jul 24, 2023

SELL
$73.76 - $85.98 $603,061 - $702,972
-8,176 Reduced 7.49%
100,969 $8.24 Million
Q1 2023

May 12, 2023

SELL
$71.62 - $86.62 $875,053 - $1.06 Million
-12,218 Reduced 10.07%
109,145 $8.1 Million
Q4 2022

Feb 10, 2023

BUY
$80.67 - $352.29 $7.28 Million - $31.8 Million
90,267 Added 290.28%
121,363 $10.1 Million
Q3 2022

Nov 09, 2022

SELL
$282.54 - $391.85 $113,016 - $156,740
-400 Reduced 1.27%
31,096 $8.83 Million
Q2 2022

Aug 16, 2022

SELL
$322.67 - $449.65 $3,226 - $4,496
-10 Reduced 0.03%
31,496 $10.9 Million
Q1 2022

May 13, 2022

SELL
$353.85 - $487.79 $2.02 Million - $2.78 Million
-5,706 Reduced 15.33%
31,506 $13.6 Million
Q4 2021

Feb 15, 2022

BUY
$456.15 - $525.06 $267,760 - $308,210
587 Added 1.6%
37,212 $19.3 Million
Q3 2021

Nov 09, 2021

BUY
$444.87 - $538.88 $25,802 - $31,255
58 Added 0.16%
36,625 $17.7 Million
Q2 2021

Aug 13, 2021

BUY
$387.35 - $450.26 $606,977 - $705,557
1,567 Added 4.48%
36,567 $16.5 Million
Q1 2021

May 11, 2021

SELL
$314.62 - $411.0 $556,877 - $727,470
-1,770 Reduced 4.81%
35,000 $13.4 Million
Q4 2020

Feb 10, 2021

BUY
$246.9 - $321.87 $1.01 Million - $1.31 Million
4,071 Added 12.45%
36,770 $11.7 Million
Q3 2020

Nov 10, 2020

BUY
$232.22 - $282.96 $7.59 Million - $9.25 Million
32,699 New
32,699 $8.1 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.